This announcement is a separate document:
宁波美诺华药业股份有限公司关于全资子公司获得达格列净片药品注册证书的公告
Announcement of Ningbo Menovo Pharmaceutical Co., Ltd.'s wholly-owned subsidiary obtaining the registration certificate for pharmaceutical Daclatasvir tablets.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.